argenx

ISIN US04016X1019

 | 

WKN A2H9WD

 

Overview

Description

argenx SE is a global immunology company, which engages in improving the lives of people suffering from severe autoimmune diseases. It operates through the following geographical segments: United States, Japan, EMEA, and China. The company was founded by Hans J. W. de Haard, Torsten Dreier, and Tim van Hauwermeiren in 2008 and is headquartered in Amsterdam, the Netherlands.
Show more Show less
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Netherlands

Financials

Key metrics

Market capitalisation, EUR 33,419.53 m
EPS, EUR -
P/B ratio 8.30
P/E ratio -
Dividend yield 0.00%

Income statement (2023)

Revenue, EUR 1,136.08 m
Net income, EUR -273.34 m
Profit margin -24.06%

What ETF is argenx in?

There are 21 ETFs which contain argenx. All of these ETFs are listed in the table below. The ETF with the largest weighting of argenx is the First Trust NYSE Arca Biotechnology UCITS ETF Acc.
ETF Weight Investment focus Holdings TER Fund size (in m EUR) Return 1Y WKN ISIN
Amundi Prime Global UCITS ETF DR (D) 0.04%
Equity
World
1,404 0.05% 805 +29.77% A2PBLJ LU1931974692
Xtrackers World Net Zero Pathway Paris Aligned UCITS ETF 1C 0.08%
Equity
World
Social/Environmental
Climate Change
1,050 0.19% 28 +26.68% DBX0RU IE000UZCJS58
Harbor Health Care UCITS ETF Accumulating 1.97%
Equity
World
Health Care
Innovation
41 0.89% 15 +6.48% A2PFPC IE00BJQTJ848
First Trust NYSE Arca Biotechnology UCITS ETF Acc 3.61%
Equity
United States
Health Care
Biotech
30 0.60% 7 +20.50% A2PZBP IE00BL0L0H60
Invesco Nasdaq Next Generation 100 UCITS ETF Acc 1.13%
Equity
United States
Technology
102 0.25% 43 +28.92% A2QPVX IE00BMD8KP97
Amundi Prime Europe UCITS ETF DR (D) 0.29%
Equity
Europe
409 0.05% 61 +12.49% A2PBLF LU1931974262
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing 0.02%
Equity
World
Multi-Factor Strategy
3,620 0.50% 62 +24.68% WELT0B IE000FPWSL69
Xtrackers EMU Net Zero Pathway Paris Aligned UCITS ETF 1C 0.87%
Equity
Europe
Social/Environmental
Climate Change
140 0.15% 7 +8.02% DBX0RW IE000Y6L6LE6
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) 1.73%
Equity
United States
Health Care
Biotech
214 0.35% 32 +19.86% A2JDYM IE00BDZVHG35
L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating 0.02%
Equity
World
Multi-Factor Strategy
3,620 0.50% 325 +25.13% WELT0A IE0001UQQ933
iShares Nasdaq US Biotechnology UCITS ETF 1.73%
Equity
United States
Health Care
Biotech
214 0.35% 440 +20.83% A2DWAW IE00BYXG2H39
Amundi Prime All Country World UCITS ETF UCITS ETF Acc 0.04%
Equity
World
2,229 0.07% 54 - ETF151 IE0003XJA0J9
L&G Global Equity UCITS ETF 0.05%
Equity
World
Social/Environmental
1,255 0.10% 215 +28.98% A2N4PQ IE00BFXR5S54
L&G Europe ex UK Equity UCITS ETF 0.36%
Equity
Europe
Social/Environmental
321 0.10% 277 +11.13% A2N4PS IE00BFXR5V83
Amundi Prime Eurozone UCITS ETF DR (C) 0.57%
Equity
Europe
190 0.05% 69 +11.23% A2PWMJ LU2089238112
Amundi Prime Eurozone UCITS ETF DR (D) 0.57%
Equity
Europe
190 0.05% 46 +12.38% A2PBLH LU1931974429
Xtrackers Europe Net Zero Pathway Paris Aligned UCITS ETF 1C 0.42%
Equity
Europe
Social/Environmental
Climate Change
306 0.15% 5 +10.97% DBX0SQ IE0001JH5CB4
Amundi Prime All Country World UCITS ETF UCITS ETF Dist 0.04%
Equity
World
2,229 0.07% 1,949 - ETF150 IE0009HF1MK9
L&G Pharma Breakthrough UCITS ETF 2.68%
Equity
World
Health Care
Innovation
37 0.49% 15 +4.47% A2H9XR IE00BF0H7608
Amundi Prime Europe UCITS ETF DR (C) 0.29%
Equity
Europe
409 0.05% 56 +13.36% A2PWMH LU2089238039
Amundi Prime Global UCITS ETF DR (C) 0.04%
Equity
World
1,404 0.05% 535 +29.72% A2PWMK LU2089238203
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.